Product information and disease description
Product description
62 evidence topics · 34 sources
Dersimelagon (MT-7117)
Erythropoietic protoporphyria or X-linked protoporphyria
- Manufacturer
- LEO Pharma
- Regulatory submission
- NDA submitted June 2026
- Launch
- Potential launch in 2027
- Last updated